🔎 Trials Near Me

Hjem › Nyrekreft (nyrecellekarcinom) › Ohio › Cleveland

Kliniske studier for Nyrekreft (nyrecellekarcinom) i Cleveland, OH

14 studier for Nyrekreft (nyrecellekarcinom) søker deltakere på steder i og rundt Cleveland (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

RekruttererFase 1
  • Research Site, Cleveland
  • Research Site, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT05536141

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

RekruttererFase 1
  • NEO-811 Cleveland Site, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07300241

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

RekruttererFase 1
  • University Hospitals Cleveland Medical Center, Cleveland
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06234605

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

RekruttererFase 1
  • Exelixis Clinical Site #10, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05176483

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

RekruttererFase 2
  • Case Western Reserve University, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi unna
  • UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT05327686

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

RekruttererObservasjonsstudie
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT05059444

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

RekruttererFase 3
  • Case Western Reserve University, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi unna
  • UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06661720

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

RekruttererFase 2
  • University Hospitals Seidman Cancer Center, Cleveland
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT05361720

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

RekruttererFase 1
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT06966024

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

RekruttererFase 1
  • Case Comprehensive Cancer Center, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2025 · NCT06805825

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

RekruttererFase 3
  • Case Western Reserve University, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi unna
  • UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2025 · NCT04510597

Nyrekreft (nyrecellekarcinom)-studier i andre byer

Andre studier i Cleveland

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.